MoneyWorks4Me

Sanjivani Paranteral board to approve un-audited financial results

17 Jul 2021 Evaluate

Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Sanjivani Paranteral has informed that the meeting of the Board of Directors of the Company is scheduled on 26/07/2021, to consider and approve the Un-Audited Financial Results of the Company for the quarter and financial year ended June 30, 2021; and any other matter with the permission of the chair.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..